Caspofungin in Candida UTI — Key Points
Short answer: Caspofungin is generally NOT recommended for Candida UTI as a first-line or routine agent. Here's why, along with the limited role it does have:
Why Echinocandins (Including Caspofungin) Are Avoided for Candida UTI
Echinocandins — caspofungin, micafungin, and anidulafungin — achieve negligible urinary concentrations. They are eliminated via non-enzymatic degradation, not renal excretion, so active drug does not accumulate in urine or bladder tissue. The IDSA 2016 guidelines explicitly state: "Echinocandins achieve therapeutic concentrations in all infection sites with the exception of the eye, CNS, and urine."
Goldman-Cecil Medicine is equally direct: "None of the newer antifungal agents has a proven role in the treatment of urinary tract infections."
Preferred Agents for Candida UTI
| Indication | Drug of Choice | Dose | Duration |
|---|
| Cystitis (susceptible isolate) | Fluconazole | 200–400 mg/day PO | 14 days |
| Pyelonephritis | Fluconazole | 200–400 mg/day PO | 14 days |
| Fluconazole-resistant (C. glabrata, C. krusei) | Amphotericin B deoxycholate | 0.3–0.6 mg/kg/day (cystitis) or 0.5–0.7 mg/kg/day (pyelo) | 1–7 days / 14 days |
| Fluconazole-resistant cystitis only | AmB bladder irrigation | 5–50 mg/L continuous | 2–7 days |
| Adjunct for renal/systemic infection | Flucytosine | 25 mg/kg QID | 7–14 days |
Table adapted from Brenner & Rector's The Kidney and IDSA 2016 guidelines.
When Caspofungin Might Be Used
Caspofungin has a role in Candida infections at other sites (candidemia, intra-abdominal, esophageal, endocarditis, osteoarticular), where standard dosing applies:
- Loading dose: 70 mg IV on Day 1
- Maintenance: 50 mg IV once daily
- Hepatic impairment (moderate): Reduce maintenance to 35 mg/day
For Candida UTI specifically, caspofungin would only be considered in exceptional situations (e.g., refractory infection with no other viable option, or systemic candidemia arising from the urinary tract) — not as primary UTI therapy.
Bottom Line
For Candida cystitis or pyelonephritis, caspofungin is not appropriate due to poor urinary penetration. Fluconazole 200–400 mg/day for 14 days remains the standard of care per IDSA and major nephrology/infectious disease references. AmB deoxycholate is the fallback for resistant species.